Рассчитайте 10-летний риск развития сердечно-сосудистых заболеваний в результате атеросклероза
Информация на сайте представлена в ознакомительных целях. Обратитесь к врачу, преждем чем использовать советы, приведенные на сайте
Risk Reduction by Therapy
Therapy(s) | Projected ASCVD Risk for this patient if Therapy Initiated |
---|---|
Statin* | |
BP drug(s)** | |
Stop smoking† | |
Aspirinǂ | |
Statin + Aspirin | |
BP drug(s) + Aspirin | |
Statin + BP drug(s) | |
Statin + Stop smoking | |
Stop smoking + Aspirin | |
BP drug(s) + Stop smoking | |
Statin + BP drug(s) + Aspirin | |
BP drug(s) + Stop smoking + Aspirin | |
Statin + BP drug(s) + Stop smoking | |
Statin + Stop smoking + Aspirin | |
Statin + BP drug(s) + Stop smoking + Aspirin |
**Start blood-pressure lowering medication if not currently taking, or add BP-lowering med (s) to patient’s existing regime.
†Stop smoking for two years
ǂStart or continue taking aspirin.
¶ NA = Not Applicable. Risk is not shown for therapy(s) that are not recommended. Guidelines do not recommend statin therapy for patients with 10-year ASCVD risk <5%. Guidelines do not typically recommend aspirin therapy for patients with 10-year risk <10%. ACC/AHA Guidelines do not specify antihypertensive drug therapy for SBP<120 mmHg (<130 mmHg w/diabetes)
Review Therapy Advice for this Patient
Continue usual care at MD’s discretion.
- BP:
- LDL-C:
- Aspirin:
- Smoking:
Lifestyle: This tool is meant to help decision making around use of statin, blood pressure medication, aspirin, and smoking cessation to lower risk, based on a particular evidence base. However, AHA/ACC guidelines stress the importance of lifestyle modification as the foundation to lowering cardiovascular disease risk, and decisions around these therapies are assumed to be in the context of guideline-recommended lifestyle interventions.
Project Risk Reduction by Therapy
Projected 10-Year ASCVD Risk
T1 15.3 % Stop Smoking, Add Statin Treatments
Add New Treatment Scenario
*Guidelines do not typically recommend aspirin therapy for patients with 10-year risk < 10%
*ACC/AHA Guidelines do not specify antihypertensive drug therapy for SBP<120 mmHg (<130 mmHg w/diabetes)
Projected 10-Year ASCVD Risk
T2 15.3 % Stop Smoking, Add Statin Treatments
Project a Different Therapy Combination
*Guidelines do not typically recommend aspirin therapy for patients with 10-year risk < 10%
*ACC/AHA Guidelines do not specify antihypertensive drug therapy for SBP<120 mmHg (<130 mmHg w/diabetes)
Projected 10-Year ASCVD Risk
T3 15.3 % Stop Smoking, Add Statin Treatments
Project a Different Therapy Combination
*Guidelines do not typically recommend aspirin therapy for patients with 10-year risk < 10%
*ACC/AHA Guidelines do not specify antihypertensive drug therapy for SBP<120 mmHg (<130 mmHg w/diabetes)
Visit Summary Below is a summary of patient’s risk, treatment options, and treatment advice based on the data provided.
Estimated 10-Year ASCVD Risk Profile
- Actual Risk
- Projected Risk
- A = Start or continue taking aspirin
- B = Start, add, or intensify blood pressure medication
- C = Manage cholesterol by starting or intensifying statin
- S = Stop smoking for at least 2 years
Treatment Advice Summary
ACC Lifestyle Recommendations
LDL-C Therapy Advice for this Patient
Blood Pressure Therapy Advice for this Patient
Therapy Safety Information
Inputs
- Sex: Female
- Race: White
Values | Previous | Current | Current |
---|---|---|---|
Age: | |||
Total Cholesterol (mg/dL) (mmol/L) | 240 | ||
Холестерин-ЛПВП (mg/dL) (ммоль/л) | |||
Холестерин-ЛПНП (mg/dL) (ммоль/л) | |||
Систолическое артериальное давление (мм рт. ст.) | 98 | 140 | |
Диастолическое кровяное давление (мм рт. ст.) | 98 | 140 | |
Diabetes: | |||
Smoker: | |||
Treatment for Hypertension: | Да | ||
Aspirin Therapy: | |||
Statin: |
Because the primary use of these risk estimates is to facilitate the very important discussion regarding risk reduction through lifestyle change, the imprecision introduced is small enough to justify proceeding with lifestyle change counseling informed by these results.
Disclaimer
The results and recommendations provided by this application are intended to inform but do not replace clinical judgment. Therapeutic options should be individualized and determined after discussion between the patient and their care provider.
C оригинальным калькулятором можно ознакомиться тут. Калькулятор разработан при поддержке Американской коллегией кардиологов на основе медицинского руководства 2013 Prevention Guidelines Tools CV Risk Calculator